Removing Harmful Antibodies

 

Problem

AMR is a growing global threat to human health and economic development.

According to the World Health Organization (WHO), it has already reached alarming levels in many parts of the world. Globally, AMR is responsible for 700,000 deaths with a significant economic burden per year.

 

 

 

Overview of the problem

AMR is a growing global threat to human health and economic development.

According to the World Health Organization (WHO), it has already reached alarming levels in many parts of the world.
Globally, AMR is responsible for 700,000 deaths with a significant economic burden per year.

By 2050, it is estimated that AMR might cause more deaths than cancer.
According to recent estimations by the World Bank, a failure to address this problem may also result in a global economic damage on par with 2008 financial crisis.

AMR could reduce Gross domestic product (GDP)
substantially and affect low-income countries the most

AMR & top 10 causes of death

 

 

 

Source European Comission

 

 

 

 

Intensive Care Unit (ICU) is the worst scenario for AMR

 

Hospital-acquired infections (HAIs) are a major cause of morbidity, mortality and costs in ICU worldwide.

  • 51% of the ICU patients worldwide have HAIs.
  • 70% of infections in ICU are due to Gram-negative bacteria. 60% mortality rates in noncardiac ICU.
  • 35% death risk increases for ICU patients.
  • 40% ICU costs increase (longer stays and treatments).

The incidence of ICU-acquired infections in patients who stay more than two days ranges from 5% to almost 25% depending on the geographical location of the ICU and is much higher in developing countries.

Hospitals have to effectively protect patients against Gram-negative infections. Our project will have a major impact on:

  • The clinical outcome of patients.
  • Reduction of antibiotic consumption and therefore a direct effect avoiding AMR.
  • Reduction of the stay in the ICU.
  • Reduction of overall costs and improvement of the efficiency of the health care system.

Find out RemAb’s solution